Third Rock Ventures III L.P. 13D/13G Filings for Relay Therapeutics, Inc. (RLAY)

Third Rock Ventures III L.P. 13D and 13G filings for Relay Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-14
4:52 pm
Sale		 2021-12-31 13G Relay Therapeutics, Inc.
RLAY		 Third Rock Ventures III L.P. 362,619
0.300%		 -10,188,496decrease
(-96.56%)		 Filing
2021-02-16
4:12 pm
Purchase		 2020-12-31 13G Relay Therapeutics, Inc.
RLAY		 Third Rock Ventures III L.P. 10,551,115
11.700%		 10,551,115increase
(New Position)		 Filing